Latest News

We’ve known for some time now that APS Type 1 patients are at an increased risk for severe COVID-19 complications.  For this reason, we’ve all been particularly cautious and vigilant.  And, APS Type 1 patients have been urged to get vaccinated.  Last week, the FDA and CDC recommended that people who are moderately to severely…

As we continue to expand and grow our foundation, we realize that we need and want to tap into the amazing talent in our community.   If you would like to get more involved, we are looking for two volunteer chairpersons to lead vital committees that are growing in our organization.    Fundraising Chair – Are…

Meet The Smith Family! My name is Jade Smith. I live in beautiful Southern California, where I am a teacher and single mom to 2 amazing children (I’m obviously biased, but they are really cool). Geoffrey turns 15 in July of 2021, and Allyson will turn 13 in November. They are both at the ages…

Dave’s Research Corner Each quarter, we like to share a research article about APS Type 1 to help keep us all up to date.  This time, we share a recent article entitled “AIRE deficiency, from preclinical models to human APECED disease.”   Animal models are very important because they help us understand the intricacies of…

We are thrilled to welcome Dr. Maureen A. Su to the foundation Medical Advisory Committee.  Dr. Su joins Dr. Mark Anderson (University of California, San Francisco), Dr. Richard Auchus (University of Michigan), Dr. Michail Lionakis (National Institutes of Health), and Dr. Dana Orange (Rockefeller University). Dr. Su is a Professor of Microbiology/Immunology and Medical Genetics…

by Gaby Talarico Gluten sensitivity is not only felt by the APS Type 1 community, but it is also slowly becoming a very well-known and common ailment amongst the American population. Whether the reason for the recent surge is that the allergy has manifested, or that we are now just starting to understand how to…

We had a great Get Connected Zoom on May 15th. We missed you. Without breaching any confidentiality, we discussed and shared about the following topics: Alopecia and Vitiligo, including possible treatments Upcoming Virtual Symposium Covid-19 Vaccines Long-acting hydrocortisone Home calcium monitors and more We hope you can join us next time. Get Connected Zooms are…

The National Adrenal Diseases Foundation, whose mission is to inform, educate, and support those with adrenal disease and their families to improve their quality of life, publishes a regular newsletter that always contains useful information for our community. We are pleased to share the June 2021 National Adrenal Diseases Foundation Quarterly with you. Click here…

The IDF Primary Immunodeficiency Conference Is going virtually this year, and the APS Type 1 Community are invited. The conference is free for our patients and families, so please join in! There are many sessions that will interest our patients and family members of all ages, and there are three that specifically focus on APS…

The APS Type 1 Foundation continues to work closely with Dr. Lionakis and his team at the National Institutes of Health (NIH) to bring forward important information in support of the health and well-being of our community.   In collaboration with researchers around the globe, the NIH continues to evaluate of the impact of Covid-19 with…

The APS Type 1 Foundation is pleased to share this advocacy opportunity with you. Rare Disease Week on Capitol Hill brings together rare disease community members from across the country to be educated on federal legislative issues, meet other advocates, and share their unique stories with legislators. While the EveryLife Foundation for Rare Diseases had…